Violation Tracker Summary for Primary Offense Type

Offense Type: 
off-label or unapproved promotion of medical products
Penalty Total since 2000: 
$20,135,257,853
Number of Penalty Records: 
118
Note: 
The totals here are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Pfizer$3,373,675,00010
Johnson & Johnson$3,136,000,00010
GlaxoSmithKline$3,004,361,8604
AbbVie$2,514,000,0007
Eli Lilly$1,608,100,0009
Merck$1,422,000,0007
Amgen$833,000,0003
Merck KGaA (EMD)$704,000,0002
AstraZeneca$594,000,0004
Bristol-Myers Squibb$534,500,0003


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML
Company Parent Parent Major Industry Year Agencysort icon Penalty Amount
Eli Lilly Eli Lilly pharmaceuticals 2010 AR-AG $18,500,000
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2017 CA-INS $1,100,000
Cephalon, Inc. Teva Pharmaceutical Industries pharmaceuticals 2008 CT-AG $6,150,000
Eli Lilly and Co. Eli Lilly pharmaceuticals 2009 CT-AG $25,100,000
Victory Pharma Inc.   2012 DOJ_CIVIL $11,420,743
Endoscopic Technologies Inc.   2009 DOJ_CIVIL $1,400,000
Bristol-Myers Squibb Company Bristol-Myers Squibb pharmaceuticals 2007 DOJ_CIVIL $515,000,000
Medicis Pharmaceutical Corporation Bausch Health pharmaceuticals 2007 DOJ_CIVIL $9,800,000
Globus Medical Inc. Globus Medical medical equipment 2012 FDA $550,000
Endo Health Solutions Inc. Endo International pharmaceuticals 2014 FDA $192,700,000
Johnson & Johnson Johnson & Johnson pharmaceuticals 2013 FDA $2,200,000,000
Wyeth Pharmaceuticals Inc. Pfizer pharmaceuticals 2013 FDA $490,900,000
Par Pharmaceutical Companies Inc. Endo International pharmaceuticals 2013 FDA $45,000,000
GlaxoSmithKline LLC GlaxoSmithKline pharmaceuticals 2012 FDA $3,000,000,000
Abbott Laboratories Inc. AbbVie pharmaceuticals 2012 FDA $1,500,000,000
Cypress Pharmaceutical Inc. Currax Pharmaceuticals pharmaceuticals 2012 FDA $2,800,000
Merck, Sharp & Dohme Merck pharmaceuticals 2011 FDA $950,000,000
Pfizer Inc. Pfizer pharmaceuticals 2011 FDA $14,500,000
Scios Inc. Johnson & Johnson pharmaceuticals 2011 FDA $85,000,000
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2011 FDA $25,000,000
UCB Inc. UCB pharmaceuticals 2011 FDA $34,000,000
Forest Pharmaceuticals Inc. AbbVie pharmaceuticals 2011 FDA $164,000,000
Elan Corporation PLC Perrigo pharmaceuticals 2010 FDA $203,000,000
Eisai Inc. Eisai pharmaceuticals 2010 FDA $11,000,000
Novartis Pharmaceuticals Corporation Novartis pharmaceuticals 2010 FDA $422,500,000
Allergan Inc. AbbVie pharmaceuticals 2010 FDA $600,000,000
Ortho-McNeil Pharmaceutical LLC Johnson & Johnson pharmaceuticals 2010 FDA $81,000,000
AstraZeneca LP AstraZeneca pharmaceuticals 2010 FDA $520,000,000
Amgen Inc. Amgen pharmaceuticals 2012 FDA $762,000,000
Warner Chilcott PLC AbbVie pharmaceuticals 2015 FDA $125,000,000
Google Inc. Alphabet Inc. internet services 2011 FDA $500,000,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical pharmaceuticals 2014 FDA $56,500,000
Healthpoint Ltd. and DFB Pharmaceuticals   2012 FDA $28,000,000
Boehringer Ingelheim Pharmaceuticals Inc. Boehringer Ingelheim pharmaceuticals 2012 FDA $95,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation Novartis pharmaceuticals 2010 FDA $72,500,000
Atricure Inc. AtriCure medical devices 2010 FDA $3,760,000
Spectranetics Corporation Royal Philips diversified 2009 FDA $5,000,000
Pfizer Inc. Pfizer pharmaceuticals 2009 FDA $2,300,000,000
Eli Lilly and Company Eli Lilly pharmaceuticals 2009 FDA $1,415,000,000
Cephalon Inc Teva Pharmaceutical Industries pharmaceuticals 2008 FDA $425,000,000
Otsuka American Pharmaceutical Inc. Otsuka Pharmaceutical pharmaceuticals 2008 FDA $4,000,000
Cell Therapeutics Inc.   2007 FDA $10,500,000
Serono, S.A. Merck KGaA (EMD) pharmaceuticals 2005 FDA $704,000,000
Warner-Lambert Pfizer pharmaceuticals 2004 FDA $430,000,000
Eli Lilly and Company Eli Lilly pharmaceuticals 2005 FDA $36,000,000
InterMune Inc. Roche pharmaceuticals 2006 FDA $36,900,000
Eli Lilly and Co. Eli Lilly pharmaceuticals 2009 ID-AG $13,000,000
Insys Therapeutics Inc. Insys Therapeutics pharmaceuticals 2017 IL-AG $4,450,000
AstraZeneca AstraZeneca pharmaceuticals 2013 KY-AG $5,500,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2010 KY-AG $3,700,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2009 KY-AG $661,860
Eli Lilly Eli Lilly pharmaceuticals 2010 LA-AG $20,000,000
Florida Men's Medical Clinic, LLC and Men's Medical Clinic, LLC   2016 MA-AG $17,000,000
Insys Therapeutics, Inc. Insys Therapeutics pharmaceuticals 2017 MA-AG $500,000
Janssen Pharmaceuticals, Inc. Johnson & Johnson pharmaceuticals 2013 MA-AG $15,100,000
Mylan Specialty, L.P. Mylan pharmaceuticals 2013 MA-AG $250,000
Pfizer Inc. Pfizer pharmaceuticals 2013 MA-AG $375,000
Stryker Biotech Stryker medical supplies 2010 MA-AG $135,000
Eli Lilly Eli Lilly pharmaceuticals 2010 MS-AG $18,500,000
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. Johnson & Johnson pharmaceuticals 2014 MT-AG $5,900,000
Abbott Laboratories AbbVie pharmaceuticals 2012 MULTI-AG (*) $339,148,643
Allergan Inc. AbbVie pharmaceuticals 2010 MULTI-AG (*) $14,750,000
Amgen Inc. Amgen pharmaceuticals 2012 MULTI-AG (*) $612,000,000
Amgen Inc. Amgen pharmaceuticals 2015 MULTI-AG $71,000,000
AstraZeneca Pharmaceuticals AstraZeneca pharmaceuticals 2011 MULTI-AG $68,500,000
AstraZeneca Pharmaceuticals LP AstraZeneca pharmaceuticals 2010 MULTI-AG (*) $218,092,993
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim pharmaceuticals 2017 MULTI-AG $13,500,000
Boehringer-Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim pharmaceuticals 2012 MULTI-AG (*) $95,000,000
Bristol-Myers Squibb Bristol-Myers Squibb pharmaceuticals 2016 MULTI-AG $19,500,000
CareFusion Becton Dickinson medical supplies 2014 MULTI-AG (*) $40,100,000
Celgene Corp. Bristol-Myers Squibb pharmaceuticals 2017 MULTI-AG (*) $20,700,000
Cephalon Inc. Teva Pharmaceutical Industries pharmaceuticals 2008 MULTI-AG (*) $116,000,000
Eisai Inc. Eisai pharmaceuticals 2010 MULTI-AG (*) $4,658,249
Elan Corp. Perrigo pharmaceuticals 2010 MULTI-AG (*) $43,399,040
Eli Lilly and Company Eli Lilly pharmaceuticals 2009 MULTI-AG (*) $361,828,456
Eli Lilly and Company Eli Lilly pharmaceuticals 2008 MULTI-AG $62,000,000
Endo Health Solution Endo International pharmaceuticals 2014 MULTI-AG (*) $173,000,000
Genentech Inc. Roche pharmaceuticals 2000 MULTI-AG $19,000,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2012 MULTI-AG (*) $477,792,391
Healthpoint Ltd.   2013 MULTI-AG (*) $28,000,000
Inspire Pharmaceuticals Merck pharmaceuticals 2015 MULTI-AG (*) $6,000,000
InterMune Inc. Roche pharmaceuticals 2006 MULTI-AG (*) $6,700,000
ISTA Pharmaceuticals, Inc. Bausch Health pharmaceuticals 2013 MULTI-AG (*) $390,253
Janssen Pharmaceuticals, Inc. Johnson & Johnson pharmaceuticals 2012 MULTI-AG $181,000,000
Johnson & Johnson Johnson & Johnson pharmaceuticals 2013 MULTI-AG (*) $541,000,000
Medicis Pharmaceutical Corporation Bausch Health pharmaceuticals 2007 MULTI-AG (*) $4,000,000
Merck Sharp & Dohme Corp. Merck pharmaceuticals 2012 MULTI-AG (*) $201,975,000
Novartis Pharmaceuticals Corporation Novartis pharmaceuticals 2010 MULTI-AG (*) $88,258,694
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation Novartis pharmaceuticals 2010 MULTI-AG (*) $29,000,000
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2011 MULTI-AG (*) $3,574,209
Organon Merck pharmaceuticals 2014 MULTI-AG $31,000,000
Ortho-McNeil Pharmaceutical LLC Johnson & Johnson pharmaceuticals 2010 MULTI-AG (*) $24,681,516
Otsuka American Pharmaceutical Inc. Otsuka Pharmaceutical pharmaceuticals 2008 MULTI-AG (*) $1,700,000
Par Pharmaceutical Companies Inc. Endo International pharmaceuticals 2013 MULTI-AG (*) $22,500,000
Pfizer Pfizer pharmaceuticals 2014 MULTI-AG $35,000,000
Pfizer Inc. Pfizer pharmaceuticals 2008 MULTI-AG $60,000,000
Pfizer Inc. Pfizer pharmaceuticals 2012 MULTI-AG $42,900,000
Purdue Pharma Purdue Pharma pharmaceuticals 2007 MULTI-AG $19,500,000
Schering-Plough Corporation Merck pharmaceuticals 2006 MULTI-AG (*) $91,602,000
Serono Inc. Merck KGaA (EMD) pharmaceuticals 2005 MULTI-AG (*) $262,000,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical pharmaceuticals 2014 MULTI-AG (*) $20,786,034
Download results as CSV or XML
(*): Some penalties are partial or complete duplicates of other penalty records, either because a DOJ settlement duplicates an agency record or because EPA listed the full penalty for a company for each of the company's relevant facilities. Penalty amounts marked with an asterisk have been identified by Good Jobs First as duplicating other penalty amounts.